Given the increasing number of government and stakeholder debates and forums around gene therapies, a global pharmaceutical company asked CRA to set out the critical policy areas that impact gene therapies and develop descriptions and positions for each topic.
CRA Approach
Given the increasing number of government and stakeholder debates and forums around gene therapies, a global pharmaceutical company asked CRA to set out the critical policy areas that impact gene therapies and develop descriptions and positions for each topic.
Client Impact
- A public affairs toolkit intended to guide cross-functional colleagues in understanding and responding to the current debate on the policy framework for gene therapies
- Additional context and guidance, with supporting evidence from case studies and country archetypes
